Masteller E - Search Results

1

Synergy of Immune Checkpoint Blockade with a Novel Synthetic Consensus DNA Vaccine Targeting TERT.

Duperret EK, Wise MC, Trautz A, Villarreal DO, Ferraro B, Walters J, Yan J, Khan A, Masteller E, Humeau L, Weiner DB. Duperret EK, et al. Among authors: masteller e. Mol Ther. 2018 Feb 7;26(2):435-445. doi: 10.1016/j.ymthe.2017.11.010. Epub 2017 Nov 21. Mol Ther. 2018. PMID: 29249395 Free PMC article.

2

Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti-CTLA-4 Antibodies Induces Tumor Shrinkage In Vivo.

Duperret EK, Trautz A, Stoltz R, Patel A, Wise MC, Perales-Puchalt A, Smith T, Broderick KE, Masteller E, Kim JJ, Humeau L, Muthumani K, Weiner DB. Duperret EK, et al. Among authors: masteller e. Cancer Res. 2018 Nov 15;78(22):6363-6370. doi: 10.1158/0008-5472.CAN-18-1429. Epub 2018 Oct 4. Cancer Res. 2018. PMID: 30287678 Free PMC article.

3

Adjuvant Screen Identifies Synthetic DNA-Encoding Flt3L and CD80 Immunotherapeutics as Candidates for Enhancing Anti-tumor T Cell Responses.

Thorne AH, Malo KN, Wong AJ, Nguyen TT, Cooch N, Reed C, Yan J, Broderick KE, Smith TRF, Masteller EL, Humeau L. Thorne AH, et al. Among authors: masteller el. Front Immunol. 2020 Feb 25;11:327. doi: 10.3389/fimmu.2020.00327. eCollection 2020. Front Immunol. 2020. PMID: 32161596 Free PMC article.

4

Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.

Masteller EL, Warner MR, Ferlin W, Judkowski V, Wilson D, Glaichenhaus N, Bluestone JA. Masteller EL, et al. J Immunol. 2003 Nov 15;171(10):5587-95. doi: 10.4049/jimmunol.171.10.5587. J Immunol. 2003. PMID: 14607967

5

Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potential.

Masteller EL, Tang Q, Bluestone JA. Masteller EL, et al. Semin Immunol. 2006 Apr;18(2):103-10. doi: 10.1016/j.smim.2006.01.004. Epub 2006 Feb 3. Semin Immunol. 2006. PMID: 16458533 Review.

6

Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice.

Masteller EL, Warner MR, Tang Q, Tarbell KV, McDevitt H, Bluestone JA. Masteller EL, et al. J Immunol. 2005 Sep 1;175(5):3053-9. doi: 10.4049/jimmunol.175.5.3053. J Immunol. 2005. PMID: 16116193

7

Peptide specific amelioration of T cell mediated pathogenesis in murine type 1 diabetes.

Judkowski V, Rodriguez E, Pinilla C, Masteller E, Bluestone JA, Sarvetnick N, Wilson DB. Judkowski V, et al. Among authors: masteller e. Clin Immunol. 2004 Oct;113(1):29-37. doi: 10.1016/j.clim.2004.03.007. Clin Immunol. 2004. PMID: 15380527

8

Immunotherapy of insulin-dependent diabetes mellitus.

Masteller EL, Bluestone JA. Masteller EL, et al. Curr Opin Immunol. 2002 Oct;14(5):652-9. doi: 10.1016/s0952-7915(02)00375-8. Curr Opin Immunol. 2002. PMID: 12183168 Review.

9

A peptide of glutamic acid decarboxylase 65 can recruit and expand a diabetogenic T cell clone, BDC2.5, in the pancreas.

Dai YD, Jensen KP, Lehuen A, Masteller EL, Bluestone JA, Wilson DB, Sercarz EE. Dai YD, et al. Among authors: masteller el. J Immunol. 2005 Sep 15;175(6):3621-7. doi: 10.4049/jimmunol.175.6.3621. J Immunol. 2005. PMID: 16148106

10

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.

Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J, Masteller EL, McDevitt H, Bonyhadi M, Bluestone JA. Tang Q, et al. J Exp Med. 2004 Jun 7;199(11):1455-65. doi: 10.1084/jem.20040139. J Exp Med. 2004. PMID: 15184499 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters